未登录

T

Tessa Fulton-Lieuw

University of Birmingham

H指数:10

被引数:1,467

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Diagnostic Performance of Ultrasound vs Ultrasound-Guided FNAC in Thyroid Nodules: Data From the ElaTION Trial

超声与超声引导下FNAC在甲状腺结节中的诊断性能: 来自ElaTION试验的数据

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IF5.1

2024-10-031

OA

Evaluation of US Elastography in Thyroid Nodule Diagnosis: The ElaTION Randomized ControlTrial

超声弹性成像在甲状腺结节诊断中的应用: 一项随机对照试验

IF15.2

2024-10-011

PRE

Real-time ultrasound elastography in the diagnosis of newly identified thyroid nodules in adults: the ElaTION RCT

实时超声弹性成像诊断新发现的成人甲状腺结节: ElaTION RCT

HEALTH TECHNOLOGY ASSESSMENT

IF4

2024-08-010

OA

PET-CT-guided, symptom-based, patient-initiated surveillance versus clinical follow-up in head neck cancer patients (PETNECK2): study protocol for a multicentre feasibility study and non-inferiority, randomised, phase III trial (vol 24, 823, 2024)

IF3.4

2024-07-180

OAAI

PET-CT-guided, symptom-based, patient-initiated surveillance versus clinical follow-up in head neck cancer patients (PETNECK2): study protocol for a multicentre feasibility study and non-inferiority, randomised, phase III trial

Pet-ct引导，基于症状，患者发起的监测与头颈癌患者的临床随访 (PETNECK2): 多中心可行性研究和非劣效性，随机，III期试验的研究方案

IF3.4

2024-07-101

OAAI

Clinicians' Views of Patient-initiated Follow-up in Head and Neck Cancer: a Qualitative Study to Inform the PETNECK2 Trial

CLINICAL ONCOLOGY

IF3

2022-04-0114

OAAI

Improvement in Dysphagia Outcomes Following Clinical Target Volume Reduction in the De-ESCALaTE Study

CLINICAL ONCOLOGY

IF3

2021-12-013

OAAI

Concurrent cisplatin or cetuximab with radiotherapy for HPV-positive oropharyngeal cancer: Medical resource use, costs, and quality-adjusted survival from the De-ESCALaTE HPV trial

EUROPEAN JOURNAL OF CANCER

IF7.1

2020-01-0113

OAAI

New insights from the De-ESCALate HPV trial

RADIOTHERAPY AND ONCOLOGY

IF5.3

2019-03-010

OAAI

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial

IF88.5

2019-01-01703

OAAI

Mehanna, Hisham; Robinson, Max; Hartley, Andrew; Kong, Anthony; Foran, Bernadette; Fulton-Lieuw, Tessa; Dalby, Matthew; Mistry, Pankaj; Sen, Mehmet; O'Toole, Lorcan; Al Booz, Hoda; Dyker, Karen; Moleron, Rafael; Whitaker, Stephen; Brennan, Sinead; Cook, Audrey; Griffin, Matthew; Aynsley, Eleanor; Rolles, Martin; De Winton, Emma; Chan, Andrew; Srinivasan, Devraj; Nixon, Ioanna; Grumett, Joanne; Leemans, C. Rene; Buter, Jan; Henderson, Julia; Harrington, Kevin; McConkey, Christopher; Gray, Alastair; Dunn, Janet